- Home
- PPBT vs LDWY Comparison
PPBT vs LDWY Comparison
Compare PPBT & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PPBT | LDWY |
|---|---|---|
| Founded | 2010 | 1990 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5M | 6.2M |
| IPO Year | N/A | 1991 |
Fundamental Metrics
Financial Performance| Metric | PPBT | LDWY |
|---|---|---|
| Price | $0.65 | $3.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 718.6K | 55.1K |
| Earning Date | 11-14-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.70 |
| Revenue | N/A | ★ $69,769,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $4.96 |
| Revenue Growth | N/A | ★ 121.91 |
| 52 Week Low | $0.53 | $3.11 |
| 52 Week High | $5.20 | $6.19 |
Technical Indicators
Market Signals| Indicator | PPBT | LDWY |
|---|---|---|
| Relative Strength Index (RSI) | 37.78 | 42.77 |
| Support Level | $0.64 | $3.34 |
| Resistance Level | $0.87 | $3.52 |
| Average True Range (ATR) | 0.04 | 0.19 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 8.60 | 30.68 |
Price Performance
Historical ComparisonAbout PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in industries: Specialty Ag, consisting of the Bloomia business.